Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Sotagliflozin in Symptomatic Obstructive and Non-obstructive Hypertrophic Cardiomyopathy [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the efficacy and safety of sotagliflozin in symptomatic obstructive and non-obstructive hypertrophic cardiomyopathy is currently active…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertrophic Cardiomyopathy
• Obstructive Cardiomyopathy

Drugs mentioned

• Sotagliflozin (sotagliflozin)

Snippet

Sponsor: Lexicon Pharmaceuticals | Conditions: Obstructive Cardiomyopathy, Hypertrophic, Non-obstructive Hypertrophic Cardiomyopathy | Phase 3 | Status: ACTIVE_NOT_RECRUITING